Stock Earnings

Question 1

What are Corbus Pharmaceuticals Holdings Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Corbus Pharmaceuticals Holdings Inc has a total asset of $155, Net loss of $-40

Question 2

What are the key financial ratios for CRBP?

Accepted Answer

Corbus Pharmaceuticals Holdings Inc's Current ratio is 11.92, has a Net margin is 0, sales per share of $0.

Question 3

How is Corbus Pharmaceuticals Holdings Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Corbus Pharmaceuticals Holdings Inc data is not available.

Question 4

Is Corbus Pharmaceuticals Holdings Inc profitable?

Accepted Answer

no, according to the latest financial statements, Corbus Pharmaceuticals Holdings Inc has a net loss of $-40

Question 5

Does Corbus Pharmaceuticals Holdings Inc have any liabilities?

Accepted Answer

yes, Corbus Pharmaceuticals Holdings Inc has liability of 13

Question 6

How many outstanding shares for Corbus Pharmaceuticals Holdings Inc?

Accepted Answer

Corbus Pharmaceuticals Holdings Inc has a total outstanding shares of 12.17

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	3
Revenue Growth (YoY)	--	--	--	--	-100%	-92%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	16	16	14	18	20	28
Research & Development	50	--	31	16	36	98
Operating Expenses	67	49	45	34	56	126
Other Non Operating Income (Expenses)	1	9	3	0	11	13
Pretax Income	-57	-40	-45	-42	-45	-111
Income Tax Expense	--	--	--	--	--	--
Net Income	-57	-40	-45	-42	-45	-111
Net Income Growth	68%	-11%	7%	-7%	-59%	56%
Shares Outstanding (Diluted)	12.24	11	4.33	4.17	4.1	2.6
Shares Change (YoY)	11%	154%	4%	2%	57.99%	22%
EPS (Diluted)	-4.73	-3.63	-10.39	-10.15	-11.13	-42.79
EPS Growth	49%	-65%	2%	-9%	-74%	28%
Free Cash Flow	-57	-41	-36	-37	-48	-100
Free Cash Flow Per Share	-4.65	-3.72	-8.31	-8.87	-11.7	-38.46
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	-4,066.66%
Profit Margin	0%	0%	0%	0%	0%	-3,700%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-3,333.33%
EBITDA	-67	-49	-45	-34	-54	-121
EBITDA Margin	0%	0%	0%	0%	0%	-4,033.33%
D&A For EBITDA	0	0	0	0	1	1
EBIT	-67	-49	-45	-34	-55	-122
EBIT Margin	0%	0%	0%	0%	0%	-4,066.66%
Effective Tax Rate	--	--	--	--	--	--

Corbus Pharmaceuticals Holdings Inc (CRBP) Price